Efficiency, Safety and Portability of Neovasculgen

Clinical trial NCT03068585 · COMPLETED

Trial details

NCT number: NCT03068585
Sponsor: Artgen Biotech
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Peripheral Arterial Disease

Start date: 2010-02-01
Primary completion: 2011-06-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.